Literature DB >> 9497963

Bipolar disorder associated with interferon-alpha treatment.

I Iancu1, A Sverdlik, P N Dannon, E Lepkifker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9497963      PMCID： PMC2431537          DOI： 10.1136/pgmj.73.866.834

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  12 in total

1.  Interferon enhances the excitability of cultured neurones.

Authors:  M C Calvet; I Gresser
Journal:  Nature       Date:  1979-04-05       Impact factor: 49.962

2.  Fluoxetine treatment of depression caused by interferon-alpha.

Authors:  J L Levenson; H J Fallon
Journal:  Am J Gastroenterol       Date:  1993-05       Impact factor: 10.864

3.  Interferon-alpha can be used successfully in patients with hepatitis C virus-positive chronic hepatitis who have a psychiatric illness.

Authors:  D H Van Thiel; L Friedlander; P J Molloy; S Fagiuoli; R J Kania; P Caraceni
Journal:  Eur J Gastroenterol Hepatol       Date:  1995-02       Impact factor: 2.566

4.  Psychiatric complications of long-term interferon alfa therapy.

Authors:  P F Renault; J H Hoofnagle; Y Park; K D Mullen; M Peters; D B Jones; V Rustgi; E A Jones
Journal:  Arch Intern Med       Date:  1987-09

5.  Safety and tolerance of recombinant interferon alfa-2a (Roferon-A) in cancer patients.

Authors:  G J Jones; L M Itri
Journal:  Cancer       Date:  1986-04-15       Impact factor: 6.860

6.  Clinical studies of recombinant interferon alfa-2a (Roferon-A) in cancer patients.

Authors:  T Taguchi
Journal:  Cancer       Date:  1986-04-15       Impact factor: 6.860

7.  Neuropsychiatric manifestations of human leukocyte interferon therapy in patients with cancer.

Authors:  F Adams; J R Quesada; J U Gutterman
Journal:  JAMA       Date:  1984-08-17       Impact factor: 56.272

8.  Treatment of renal cell carcinoma with escalating doses of alpha-interferon.

Authors:  N Tsavaris; N Mylonakis; C Bacoyiannis; H Tsoutsos; A Karabelis; P Kosmidis
Journal:  Chemotherapy       Date:  1993 Sep-Oct       Impact factor: 2.544

9.  Suicide associated with alfa-interferon therapy for chronic viral hepatitis.

Authors:  H L Janssen; J T Brouwer; R C van der Mast; S W Schalm
Journal:  J Hepatol       Date:  1994-08       Impact factor: 25.083

10.  Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers.

Authors:  E M McDonald; A H Mann; H C Thomas
Journal:  Lancet       Date:  1987-11-21       Impact factor: 79.321
View more
  2 in total

1.  Interferon-alpha induced mania during the adjuvant treatment of malignant melanoma.

Authors:  A M Ni Mhaolain; J H Thakore
Journal:  Ir J Med Sci       Date:  2007-03-30       Impact factor: 1.568

2.  Dual transcripts of BCR-ABL & different polymorphisms in chronic myeloid leukaemia patients.

Authors:  S Rajashree Nandagopalan; Nivedita Kuila; Sutapa Biswas; Naresh Chandra Pattnayak; Gyanashyam Biswas; Soumen Chakraborty
Journal:  Indian J Med Res       Date:  2016-05       Impact factor: 2.375
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.